NCT05153512

Brief Summary

To date, no MRI study has been published describing the prevalence of endometriosis in adolescent girls, not even in those with significant dysmenorrhea and therefore more particularly at risk. Likewise, there are no precise data on the type of superficial or early-onset deep endometriosis that appears in adolescence. The collection of these data would allow an earlier diagnosis, because it is better documented, of endometriosis. The lesions would then be treated earlier, avoiding their development and the problems of infertility related to this pathology. The aim of this sudy is to assess the prevalence of endometriosis and its phenotypic representation in the study population consulting for dysmenorrhea with suspected endometriosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 10, 2021

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2021

Completed
Last Updated

December 10, 2021

Status Verified

December 1, 2021

Enrollment Period

9 months

First QC Date

November 25, 2021

Last Update Submit

December 9, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patient with endometriosis detected on MRI

    1 day

Interventions

MRIPROCEDURE

Pelvic MRI without injection of contrast product and WITHOUT rectal or vaginal opacification

Eligibility Criteria

Age12 Years - 20 Years
Sexfemale
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women between 12 and 20 years-old and suffering from dysmenorrhea

You may qualify if:

  • Patient aged between 12 and 20 years old.
  • After menarche.
  • Requiring pelvic MRI for exploration of dysmenorrhea (after or not ultrasound), in the case of patients with suspected endometriosis, or for any other reason (cyst, tumor, non-obstructive urogenital malformations), in the case of patients without symptoms clinic associated with endometriosis.
  • Patient affiliated or beneficiary of a social security scheme.
  • Patient and her legal representative, if applicable, having been informed and not opposing this research.

You may not qualify if:

  • Patient whose pelvic MRI is performed as part of an exploration of obstructive uterine malformations.
  • Patient claustrophobic, making it impossible to perform an MRI.
  • Contraindication to MRI: pacemaker, ferromagnetic object incompatible with MRI.
  • Pregnant, breastfeeding or parturient woman.
  • Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BLOMET clinic

Paris, IDF, 75015, France

RECRUITING

Related Publications (1)

  • Millischer AE, Santulli P, Da Costa S, Bordonne C, Cazaubon E, Marcellin L, Chapron C. Adolescent endometriosis: prevalence increases with age on magnetic resonance imaging scan. Fertil Steril. 2023 Apr;119(4):626-633. doi: 10.1016/j.fertnstert.2022.12.039. Epub 2022 Dec 31.

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Central Study Contacts

Jean-François Oudet

CONTACT

Marie-Hélène Barba

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2021

First Posted

December 10, 2021

Study Start

September 26, 2019

Primary Completion

June 26, 2020

Study Completion

December 26, 2021

Last Updated

December 10, 2021

Record last verified: 2021-12

Locations